
CAS 179474-81-8: Prucalopride
Formula:C18H26ClN3O3
InChI:InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)
InChI key:InChIKey=ZPMNHBXQOOVQJL-UHFFFAOYSA-N
SMILES:C(NC1CCN(CCCOC)CC1)(=O)C2=C3C(=C(N)C(Cl)=C2)CCO3
Synonyms:- 7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-
- 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide
- Prucalopride
Sort by
Found 11 products.
Prucalopride
CAS:Prucalopride (R-93877), a selective 5-HT4A/4B agonist (Ki: 2.5/8 nM), is >290x more specific for these receptors.Formula:C18H26ClN3O3Purity:100%Color and Shape:SolidMolecular weight:367.87Prucalopride-d5
CAS:Controlled ProductFormula:C18D5H21ClN3O3Color and Shape:NeatMolecular weight:372.9014-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide
CAS:The drug 4-Amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (BZP) is a histamine H2 receptor antagonist. It binds to the histamine H2 receptor in the stomach and duodenum, thereby blocking stomach acid production. BZP has been shown to be effective for treating symptoms of constipation or diarrhoea caused by inflammatory bowel disease or abdominal surgery. BZP also reduces the risk of relapse after surgery but does not affect long term efficacy. This drug is not available in the United States and has significant interactions with other drugs and symptoms including constipation, bowel disease, long term efficacy, and analytical method.Formula:C18H26ClN3O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:367.87 g/molPrucalopride
CAS:Formula:C18H26ClN3O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:367.877-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-
CAS:Formula:C18H26ClN3O3Purity:98%Color and Shape:SolidMolecular weight:367.8703